RETRACTION: MeCP2 Drives Hepatocellular Carcinoma Progression Via Enforcing HOXD3 Promoter Methylation and Expression Through the HB-EGF/EGFR Pathway. Here, HBEGF is linked to hepatocellular carcinoma.